News Conference News TCT 2017 Experts Debate: Should Cerebral Protection Be Used for All TAVRs? Todd Neale November 09, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News TCT 2017 One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block Michael O'Riordan October 31, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Conference News PCR London Valves 2017 Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III Shelley Wood September 27, 2017
News Daily News Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis Ashley Lyles August 08, 2017
Presentation TVT 2017 Advances in Temporary Transvenous Pacemakers: The BioTrace Tempo Lead Presenter: Tamim Nazif June 15, 2017
News Conference News SCAI 2017 New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke L.A. McKeown May 12, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017
News Conference News CRT 2017 Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation Michael O'Riordan February 22, 2017
News Conference News CRT 2017 Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy Michael O'Riordan February 20, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2017 Caitlin E. Cox February 01, 2017
News Features The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol Michael O'Riordan January 24, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017
Presentation Apixaban in Patients With Atrial Fibrillation After TAVR Presenter: J. Seeger January 03, 2017